Gabelli & Co Investment Advisers’s Corcept Therapeutics CORT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,400	Closed	-$233K	–	333
2020 Q3	$233K	Sell	13,400 -1,200	-8%	-$19.1K	0.04%	171
2020 Q2	$246K	Hold	14,600	–	–	0.06%	137
2020 Q1	$174K	Hold	14,600	–	–	0.03%	151
2019 Q4	$177K	Hold	14,600	–	–	0.02%	170
2019 Q3	$206K	Hold	14,600	–	–	0.02%	160
2019 Q2	$163K	Hold	14,600	–	–	0.02%	169
2019 Q1	$171K	Hold	14,600	–	–	0.02%	145
2018 Q4	$195K	Hold	14,600	–	–	0.03%	136
2018 Q3	$205K	Hold	14,600	–	–	0.02%	159
2018 Q2	$230K	Hold	14,600	–	–	0.03%	142
2018 Q1	$240K	Sell	14,600 -2,400	-14%	-$44.5K	0.03%	133
2017 Q4	$307K	Sell	17,000 -900	-5%	-$16.3K	0.04%	118
2017 Q3	$345K	Sell	17,900 -4,100	-19%	-$61.1K	0.04%	124
2017 Q2	$260K	Sell	22,000 -5,500	-20%	-$59.8K	0.03%	146
2017 Q1	$301K	Sell	27,500 -7,700	-22%	-$67.6K	0.03%	127
2016 Q4	$256K	Sell	35,200 -52,800	-60%	-$414K	0.03%	126
2016 Q3	$572K	Sell	88,000 -7,500	-8%	-$43.6K	0.07%	101
2016 Q2	$521K	Sell	95,500 -700	-0.7%	-$3.64K	0.07%	110
2016 Q1	$450K	Hold	96,200	–	–	0.06%	111
2015 Q4	$479K	Hold	96,200	–	–	0.06%	118
2015 Q3	$362K	Hold	96,200	–	–	0.05%	130
2015 Q2	$578K	Sell	96,200 -1,800	-2%	-$11K	0.08%	108
2015 Q1	$549K	Sell	98,000 -2,000	-2%	-$7.24K	0.09%	90
2014 Q4	$300K	Hold	100,000	–	–	0.04%	116
2014 Q3	$268K	Hold	100,000	–	–	0.04%	146
2014 Q2	$280K	Hold	100,000	–	–	0.06%	105
2014 Q1	$436K	Hold	100,000	–	–	0.12%	83
2013 Q4	$321K	Hold	100,000	–	–	0.12%	81
2013 Q3	$159K	Hold	100,000	–	–	0.03%	118
2013 Q2	$173K	Buy	+100,000	New	+$180K	0.05%	111

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Gabelli & Co Investment Advisers's CORT Position: Q4 2020 in Review

Gabelli & Co Investment Advisers sold out of Corcept Therapeutics (CORT) in Q4 2020, closing a stake of 13,400 shares — an estimated $233K sold.

Gabelli & Co Investment Advisers first reported a position in CORT in Q2 2013 and held it in 30 quarters. The position peaked at $578K in Q2 2015. 226 funds tracked by Wall St. Rank hold CORT as of Q4 2020.

Gabelli & Co Investment Advisers reported no remaining Corcept Therapeutics position as of Q4 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 13,400 Corcept Therapeutics shares in Q4 2020, an estimated $233K.
Gabelli & Co Investment Advisers first reported a position in Corcept Therapeutics in Q2 2013 and held it in 30 quarters.
Gabelli & Co Investment Advisers's Corcept Therapeutics position peaked at $578K in Q2 2015.
226 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2020, filed 5 Feb 2021.